Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
US opioid prescriptions drop by a half but it’s not all good news

US opioid prescriptions drop by a half but it’s not all good news

In a dramatic shift in physician behavior, the number of new opioid prescriptions issued each month in the US has taken a nosedive, to less than a half. However, the number of high-risk prescriptions remains worryingly high, according to researchers at Harvard University.

Opioids are a class of drugs that are commonly prescribed to relieve paintab62 | Shutterstock

Patients who have never been prescribed opioids before or have been off them for six months or more are called opioid-naïve. In the new study, out of  20 million people who obtained at least one opioid prescription between 2012 and 2017, 10 million are now opioid-naïve.

In this group, the number of physicians who prescribed opioids went down by an astonishing 30% while there was a 54% decline in monthly prescriptions for opioid drugs, from 1.63 % of monthly patients to 0.75%, by the end of the study.

The number of overall and high-risk opioid prescriptions also decreased from March 2016 onwards – when the CDC guidelines were published.

The overuse of prescription opioid drugs has produced a massive epidemic of opioid misuse in the US, killing 70 000 people over the last year. Therefore, intensive efforts have been made, including pressure on lawmakers, to reduce the number of first-time opioid prescriptions, which often introduce patients or others to these drugs.

One major result was the U.S. Centers for Disease Control and Prevention (CDC) guidelines issued in March 2016, to curb risky opioid prescriptions. They recommend the use of other therapeutic modalities such as physical therapy and non-steroidal anti-inflammatory drugs (NSAIDs) wherever possible to help relieve pain.

High-risk prescriptions may be defined as a daily dose equivalent to 50 mg or more of morphine (50 morphine milligram equivalents (MME) a day). In the case of people with very severe pain, the maximum recommended dosage is 90 MME.

The guidelines recommend that no opioid at any dosage be prescribed for over three days, with one week being the absolute maximum.

The current study was based on the monthly analysis of 63.8 million privately insured patients aged 18 to 64 years between the years 2012 and 2017.

Despite the obvious reduction in opioid prescriptions, the actual percentage of high-risk prescriptions remained the same, surprisingly. About 115 000 of almost 16 million prescriptions fitted this category.

Even more worryingly, there were about 7700 prescriptions at doses above 90 MME – a dose which is associated with significant danger of both fatal and nonfatal overdose – despite the new guidelines.

Another group of healthcare providers apparently refused to prescribe opioids entirely, rather than take on the responsibility of using them appropriately. This fear is fueled, says Stefan Kertesz, an addiction specialist from the University of Alabama, by the high-powered attention on physicians from multiple stakeholders and regulatory bodies.

Kertesz commented, “In that situation, physicians tend to see the patient who might need opioids as a potential threat to the physician’s own professional survival.”

This “all-or-nothing approach” was not acceptable, since it could deprive some patients of adequate pain relief, suggested the study authors.

Another concern was that insurers sometimes misuse these guidelines to force patients to use lower opioid dosages, even for those who have achieved good pain control without addiction or misuse. In fact, Kertesz and other medical experts are lobbying for a confrontation with these agencies to safeguard patient well-being.

And finally, lack of access to prescription opioids could lead to an increase in heroin-overdose and related deaths over the following five years, before reducing new opioid addiction as intended.

It is well-known that most overdose deaths due to opioids occur with synthetic street drugs like fentanyl, though the initial exposure in a large number of cases is through prescription opioids.

The insurance claims were taken from the Blue Cross–Blue Shield (BCBS) Axis after removing all identifying details. This includes the widest collection of data relating to medical professional claims, commercial insurance claims and information about the cost of medical care.

Investigators looked at estimates of new monthly prescriptions issued to opioid-naïve individuals, those who were prescribed opioids in high doses or for prolonged periods, and the number of physicians who issued first-time opioid prescriptions to the opioid-naïve.

However, researchers could not comment on whether the clinical decision on opioids was appropriate in any case, as the data provided was non-specific.

The challenge we have in front of us is nothing short of intricate: curbing the opioid epidemic while ensuring that we appropriately treat pain. It’s a question of balancing the justified use of potent pain medications against the risk for opioid misuse and abuse.”

Nicole Maestas, Senior Investigator

The study shows that more thought needs to be put into the way a physician decides to prescribe or withhold opioids in a given clinical scenario, and also on the dose and duration of therapy, if given.

The study was published on March 14, in The New England Journal of Medicine.


Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017. NJEM. 14th March 2019.

Tagged with:

About author

Related Articles